Accelerating & Derisking Drug Development with PremiumCoat®
A Webinar Sponsored By APTAR Pharma
Choosing the right packaging for sensitive drugs, new biotech drugs or biosimilar can be a complex and risky exercise.
Aptar Pharma developed a platform of closure components, Data and Services to accelerate and derisk the choice of drug developers. In this webinar, Aptar Pharma's experts will present the series of test that were developed to demonstrate the performance of PremiumCoat® ETFE film-coated solutions. This includes Leachable simulation studies, container closure integrity, fragmentation and pop-off resistance for vial stoppers as well as functional, break-loose and gliding studies for the syringe plungers.
Aptar Pharma will explain how these data can help our Pharma partners to anticipate primary container closure challenges, facilitate their choice of primary container and even accelerate their drug development and regulatory approval by leveraging our Data packages and development service expertise.
KEY LEARNING OBJECTIVES
How to accelerate and derisk drug development by choosing the right closure solution.
ETFE film coated components help reduce extractables and leachables to protect highly sensitive drugs.
Evaluating the performance of a vial stopper is essential to ensure the drug stays protected from filling through to patient administration.
Syringe plunger functional performance is essential to ensure easy drug deliver and facilitate integration into auto-injectors.
The webinar will be of interest to the following audiences: